A long and successful heritage in China

GSK's history in China can be traced back to the early 20th century. Since the 1980s, GSK has actively invested in China. Following the completion of the global merger between Glaxo Wellcome and SmithKline Beecham, GlaxoSmithKline (China) Investment Co. Ltd. was officially established in 2001.

We are one of the largest multinational pharmaceutical companies in China. With four manufacturing sites, among which two are joint ventures, our total investment in China exceeds US$400 million. We have set up offices in major cities nationwide and employ approximately 3000 local staff.

Our business units in China include Prescription Medicines, Vaccines, Over-the-Counter (OTC) Medicines and Consumer Healthcare, headquartered separately in Shanghai, Tianjin and Hong Kong.